Metraipolis › archive › dc_94f7690fb191

Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases — Europe PMC PMID:42367766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42367766
DOI
10.3389/fimmu.2026.1875279
License (as archived)
solo-consultazione
Archived
2026-10-31T14:05:44.971Z
SHA-256 of the archived text
d1a68289e9750c17d09aaa400ca1a5fc48874283f4cf05e6f47f506164bd8c58
Stable URL of this page
https://metraipolis.com/documento/dc_94f7690fb191

How to cite

Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases — Europe PMC PMID:42367766 — Europe PMC (en), https://europepmc.org/article/MED/42367766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94f7690fb191 (Metraipolis archive dc_94f7690fb191, sha256 d1a68289e9750c17d09aaa400ca1a5fc48874283f4cf05e6f47f506164bd8c58)
BibTeX
@misc{dc94f7690fb191,
  title = {Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases — Europe PMC PMID:42367766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94f7690fb191; sha256 d1a68289e9750c17d09aaa400ca1a5fc48874283f4cf05e6f47f506164bd8c58},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367766. Agents can read the archived copy with the MCP tool read_document.